Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.
inews.co.uk on MSN
I used to take ketamine every weekend - this is what parents should know
By 2017, ketamine was increasingly a party staple in my circles. Friends introduced me to “Calvin Klein”, a mix of cocaine ...
Cytokinetics, Incorporated awaits a pivotal FDA decision on aficamten for hypertrophic cardiomyopathy. Learn more about CYTK ...
Clinical success achieved with one or two doses of TARA-002 in 88% of patientsTARA-002 demonstrated favorable safety and ...
The GA4GH is uniting researchers worldwide to share genomic data responsibly, set open standards, and improve oncology care ...
The most common side effects you may experience with Mounjaro include nausea, vomiting, diarrhea, constipation, and stomach pain. Mounjaro carries a boxed warning (the most serious type of FDA warning ...
New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...
University of Tennessee, Knoville researcher Wenjun Zhou developed an error-controlled correlation (ECC) method to improve ...
Panelists discuss how managing oral therapy toxicities requires preemptive planning, multidisciplinary team involvement, ...
The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the ...
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced positive ...
Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback